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A Ab bs st tr ra ac ct t
P Pu ur rp po os se e: : To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with
neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals
with NF-1. In order to confirm our initial results we performed EOG examination on a larger group of NF-1
patients.
P Pa at ti ie en nt ts s: : Studies were performed on 36 patients with clinically diagnosed NF-1 and compared to normal healthy
controls. 
M Me et th ho od ds s: : Standard EOG recordings were performed in accordance with the International Society for Clinical
Electrophysiology of Vision (ISCEV) standards. 
R Re es su ul lt ts s: :   In NF-1 patients the Arden indexes of the EOG test were significantly higher primarily due to the lower
values of dark troughs. Supernormal EOGs (exceeding the value of the mean + 2 SD from the control group)
were present in 58% of NF-1 patients.
C Co on nc cl lu us si io on ns s: : Dysfunction of the RPE is a characteristic feature of individuals with NF-1.
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I In nt tr ro od du uc ct ti io on n
Neurofibromatosis  type  1  (NF-1),  or  von
Recklinghausen disease is one of the most common
genetic  multisystem  progressive  disorders  with  an
incidence of approximately 1:3000 live births. In the
eye, the disorder is characterised by Lisch nodules, optic
gliomas,  choroidal  hamartomas  and  congenital
hypertrophy of the retinal pigment epithelium (CHRPE)
[1, 2]. The gene for NF-1 is localized to chromosome
17q11.2. and its protein product has been termed
neurofibromin [3, 4]. It appears that reduction of
neurofibromin expression can lead to abnormalities in
the differentiation and migration of melanoblasts and
melanocytes which gives rise to characteristic café-au-
lait  spots  of  the  skin  [5].  Café-au-lait  spots  are
characterised  by  increased  levels  of  epidermal
melanogenesis [6] and increased numbers of epidermal
melanocytes [7] which contain abnormally large pigment
granules, known as macromelanosomes. In the eye,
Lisch nodules consist of masses of melanocytes. The
choroidal  hamartoma  is  similar  to  the  iris  lesion
histopathologically. Congenital hypertrophy of retinal
pigment epithelium, a rare feature of patients with NF-
1, consists of focal areas of pigment epithelial cells that
are more densely packed with pigmented granules [8].H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(4) 194
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Retinal pigment epithelium (RPE) also contains
melanin. It can be hypothesized that changes in
neurofibromin expression are leading to some melanin
changes also in RPE of patients with NF-1. It has been
described in patients with albinism that the reduced
level or absence of retinal pigment is associated with
changes detectable by EOG [9] – the most commonly
used electrophysiological test of RPE function [10, 11]. 
Our  initial  EOG  [12]  results  suggested  that
dysfunction of the RPE may be a characteristic feature
of  individuals  with  NF-1.  In  order  to  verify  our
preliminary  findings  we  performed  the  EOG
examination in a two-fold larger group of patients
diagnosed with NF-1.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s
The EOGs were performed on 36 patients (67 eyes;
22 males, 14 females; mean age: 26.6±10.9 years;
mean refractive error: -0.21±0.72 D) who fulfilled the
National Institutes of Health clinical diagnostic criteria
for NF-1 [7, 13] and compared to 32 healthy subjects.
Ocular findings in a group of patients with NF-1 are
as follows: Snellen visual acuity – 20/20, Lisch nodules
– (65/67) 97% of analysed eyes, choroidal hamartoma
– (5/67) 7.4%, CHRPE (congenital hypertrophy of the
retinal pigment epithelium) – (4/67) 5.9%, optic nerve
glioma – (3/67) 4.4%, normal colour vision and visual
field measured by kinetic perimetry. The two groups
were similar as far as age, sex and refractive error were
concerned. Uncooperative patients were excluded from
the study. 
Electro-oculography (UTAS E-2000) was performed
according  to  the  Standard  for  EOGs  of  the
International Society for Clinical Electrophysiology of
Vision (ISCEV) Standardisation Committee [10, 11]. In
the EOG examination, patients’ pupils were dilated
(10% neo-synephrine, 1% tropicamide) and a stimulus
intensity equal to ca. 100 cd·m
-2 (aperture 1/2) was
used, which has been recommended as a standard for
the light adaptation phase in this case. We analysed
the values of the lowest potential reached during the
dark phase (dark-trough amplitude in µV, DTA), dark-
trough latency (DTL) measured in minutes, the highest
potential reached during light exposure (light-peak
amplitude in µV, LPA), light-peak latency (LPL) in minutes
and the ratio of the light-peak amplitude to dark-trough
amplitude (Arden Index, AI).
Statistical analysis was performed using parametric
(Shapiro-Wilk test, Student t-test) and non-parametric
(Mann-Whitney test) tests with a significance level of
p≤0.05. This study was approved by the Committee of
Medical Ethics of the Medical University in Szczecin. 
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R Re es su ul lt ts s
Descriptive statistics and statistical analysis of the
EOG parameters for two study groups (NF-1 patients
and normal controls) are shown in Table 1. The Student
t-test and the Mann-Whitney test revealed significant
differences  in  the  variables  DTA  (p<0.001),  AI
(p<0.001), and LPL (p<0.001). Figure 1 illustrates an
example of an NF-1 patient with supernormal AI on
EOG examination.
For the NF-1 group, the mean DTA (305.0±81.2
µV) was significantly lower than that of the control
group  (408.1±112.9  µV)  and  the  mean  AI
(3.42±0.62) was significantly higher (2.45±0.37).
The mean LPL for the NF-1 group (7.6±1.1 min) was
significantly lower than that of the control group
(8.4±1.3 min). The mean LPA of the NF-1 group
(971±229 µV) was lower than that of the normal
subjects  (982±242  µV);  this  difference  was  not
statistically significant. The mean DTL for the NF-1
group (11.6±2.2 min) was almost the same as that of
the control group (11.7±2.0 min).
In the group of patients with NF-1 we found no
subnormal  EOGs.  Supernormal  EOGs
(AI>mean+2SD – more than 3.19) were detected in
58.3% (21/36) of patients, 58.2% (34/67) of eyes.
D Di is sc cu us ss si io on n
The results of our studies suggest that dysfunction
of RPE as measured by EOG is present in patients with
NF-1. Enlargement of the analysed eyes of patients
with NF-1 (from 35 to 67 eyes) did not change
significantly the EOG results obtained in a group of
patients with NF-1 published previously [12]. We
observed a supernormal EOG (increased AIs) in 58%
of analyzed eyes in individuals with NF-1. Subnormal
EOG was not found in this group of patients. Detection
of changes by EOG and in parallel small changes in
ERG what was shown previously [12] indicating that
the occurrence of abnormalities was mainly in the RPE. 
The increased AI in NF-1 patients is a result of
relatively low DTAs. The dark-trough potential is a result
of polarisation differences between the apical and basal
membranes of RPE cells [13]. The significantly lower
amplitude  of  this  potential  suggests  that  the
mechanisms underlying polarization differences are
altered in NF-1. 
The apical membrane is more hyperpolarized than
the  basolateral  membrane.  This  variation  in
membrane potentials results from differences in the
types  and  distribution  of  transport  mechanisms
between  the  two  RPE  membranes.  Primarily  K
+
channels generate the apical membrane potential
with smaller contributions from the electrogenic
Na
+/K
+ pump and Na
+HCO3
– cotransporter. The
basolateral membrane potential is generated primarily
by a balance between Cl
– and K
+ channels [13]. The
basolateral membrane Cl
– conductance may be
modulated by intracellular Ca
2+ [14]. It is reasonable
to expect that changes in any of above transport
mechanisms can occur in NF-1.
As mentioned in the introduction there are data
indicating a correlation between the occurrence of
neurofibromin and melanin abnormalities. Melanin has
the capacity to bind and accumulate many chemicals
[15]. Pigmented cells contain particularly high amounts
T Ta ab bl le e   1 1. .   EOG in NF-1 patients - descriptive statistics and statistical analysis (36 patients)
n n N N M M   ± ±   S SD D M Mi in n M Me ed d M Ma ax x
NORM- DTA (µV) 64 + 408.1±112.9*** 198 403 798
NF-1- DTA    (µV) 67 + 305.0±81.2*** 140 296 498
NORM- DTL (min) 64 - 11.7±2.0 6 12 15
NF-1- DTL    (min) 67 - 11.6±2.2 7 12 15
NORM- LPA (µV) 64 + 982±242 445 951 1650
NF-1- LPA    (µV) 67 - 971±229 537 922 1483
NORM- LPL (min) 64 - 8.4±1.3*** 6 8 11
NF-1- LPL    (min) 67 - 7.6±1.1*** 5 7 10
NORM- AI 64 + 2.45±0.37*** 1.83 2.42 3.26
NF-1- AI 67 + 3.42±0.62*** 2.19 3.17 5.18
n – number of eyes; M – arithmetic mean; Min – minimum value; Med – median; N – normal distribution; SD – standard deviation; Max – maximum value
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of calcium, reflecting the enormous calcium binding
capacity of melanin [16]. The data obtained in the
current study suggest that supernormal EOGs in NF-
1 patients are a result of changes in calcium levels
caused by melanin abnormalities, which is related to
the reduction in expression of neurofibromin.
The lower EOG dark-trough values have been
described previously in albinism [9]. This disorder is
characterised by congenital reduction or total absence
of pigment in hair, skin and eyes [17].
This finding also supports the hypothesis that EOG
changes  in  NF-1  patients  are  associated  to
neurofibromin-mediated melanin alterations.
It is well known that in many ocular disorders
electrophysiological changes can occur independently
of alterations detectable by ophthalmoscopy. Also in
our  patients  abnormal  EOGs  were  observed  in
individuals without characteristic NF-1 fundus changes
detectable during routine examination.
NF-1 can be unequivocally diagnosed by the
detection of NF-1 gene mutations by DNA/RNA
analyses. Molecular analysis of large genes like NF-1
are still complex, time consuming and expensive. Due
to cost implications genetic analysis of NF-1 has to be
limited to the groups of pre-selected patients that have
a high probability of carrying mutations. In order to
identify such groups it is important to find as many
independent clinical features as possible that are
closely correlated with NF-1 disease expression.
The high frequency of supernormal EOGs in
patients with NF-1 suggests that this type of analysis
might be useful in the initial identification of patients
with NF-1 who do not present with the typical spectrum
of disease symptoms.
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